Anticoagulant therapy during pregnancy of patients with mechanical heart valve prostheses;Gestion du traitement anticoagulant chez la femme enceinte porteuse d'une prothèse valvulaire mécanique

Sang Thrombose Vaisseaux

Volumn 14, Issue 3, 2002, Pages 153-157

  Hanania, Guy ^a  

^a Centre Hospitalier Robert Ballanger CHRB   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; CHEMOPROPHYLAXIS; DRUG CHOICE; FETOTOXICITY; GESTATIONAL AGE; HEART VALVE PROSTHESIS; HUMAN; PREGNANCY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM;

EID: 0036255683     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Maternal and fetal sequelae of anticoagulation during pregnancy
2. Pregnancy and mechanical valve prostheses: A high-risk situation for the mother and the fetus
3. Risks of anticoagulant therapy in pregnant women with artificial heart valves
4. Pregnancy in patients with mechanical prosthetic heart valves. Our experience regarding 98 pregnancies in 57 patients
5. Pregnancy in patients with prosthetic heart valves: The effects of anticoagulation on mother, fetus, and neonate
6. Outcome of pregnancy in women with valve prostheses
7. Grossesse chez les porteuses de prothèse valvulaire. Étude coopérative rétrospective française (155 cas)
8. Dose-dependent fetal complications of Warfarin in pregnant women with mechanical heart valves
9. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves
10. A European view on the North American fifth consensus on antithrombotic therapy
11. Low molecular weight heparin after mechanical heart valve replacement
12. Management of pregnancy in women with thrombophilia
13. Safety of low-molecular-weight heparin in pregnancy-a systematic review
14. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement
15. Low molecular weight heparin in a pregnant woman with mechanical heart valve prosthesis: A case report
16. Low molecular weight heparin for prosthetic heart valves: Treatment failure
17. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses
18. Guidelines for prevention of thromboembolic events in valvular heart disease: Study group of the working group on valvular heart disease of the European Society of Cardiology
19. ACC/AHA Guidelines for the management of patients with valvular heart disease
20. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves